Supriya Lifescience Limited (NSE:SUPRIYA)

Supriya Lifescience Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	759.31	375.46	760.57	683.49	852.51	1,658
Short-Term Investments	-	413.21	30.97	66.07	723.31	591.55
Cash & Short-Term Investments	759.31	788.67	791.54	749.56	1,576	2,249
Cash Growth	-26.43%	-0.36%	5.60%	-52.43%	-29.94%	160.26%
Accounts Receivable	1,256	2,194	1,344	1,117	846.64	1,152
Other Receivables	-	-	7.11	45.09	64.06	60.32
Receivables	1,261	2,200	1,358	1,169	916.16	1,218
Inventory	2,652	1,596	1,183	852.49	1,158	923.12
Prepaid Expenses	-	92.49	102.43	112.25	108.48	72.45
Other Current Assets	1,033	645.73	985.37	1,097	890.71	512.77
Total Current Assets	5,705	5,323	4,421	3,980	4,649	4,975
Property, Plant & Equipment	7,406	7,234	5,995	4,573	3,281	2,317
Long-Term Investments	1,066	985.23	632.41	637.95	252.96	0.53
Other Intangible Assets	11.79	13.12	13.89	16.56	11.06	15.09
Other Long-Term Assets	27.92	15.81	111.54	6.8	9.28	39.82
Total Assets	14,217	13,571	11,173	9,214	8,203	7,348

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,071	1,108	745.46	595.69	642.28	489.72
Accrued Expenses	-	49.71	42.2	29.61	27.58	29.58
Short-Term Debt	-	-	-	-	166.25	212.95
Current Portion of Leases	3.18	2.46	3.23	4.68	3.54	8.25
Current Income Taxes Payable	-	-	-	-24.68	45.87	64.11
Other Current Liabilities	230.04	49.8	81.05	165.76	72.28	192.38
Total Current Liabilities	1,304	1,210	871.94	771.06	957.8	996.99
Long-Term Leases	54.85	51.89	50.57	50.2	54.89	52.95
Pension & Post-Retirement Benefits	-	1.91	-	-	47.3	26.73
Long-Term Deferred Tax Liabilities	416.2	312.44	270.18	231.52	136.75	111.49
Other Long-Term Liabilities	15.45	17.06	13.18	8.03	11.45	2.59
Total Liabilities	1,791	1,594	1,206	1,061	1,208	1,191

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	160.97	160.97	160.97	160.97	160.97	160.97
Additional Paid-In Capital	-	1,985	1,985	1,985	1,985	1,985
Retained Earnings	-	9,830	7,820	6,004	4,862	4,011
Comprehensive Income & Other	12,265	0.58	1.57	2.82	-13.42	-0.01
Shareholders' Equity	12,426	11,977	9,968	8,154	6,995	6,157
Total Liabilities & Equity	14,217	13,571	11,173	9,214	8,203	7,348

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	58.03	54.35	53.8	54.88	224.68	274.15
Net Cash (Debt)	701.28	734.32	737.74	694.68	1,351	1,975
Net Cash Growth	-28.43%	-0.46%	6.20%	-48.59%	-31.59%	1287.90%
Net Cash Per Share	8.71	9.12	9.17	8.63	16.79	24.54
Filing Date Shares Outstanding	80.58	80.48	80.48	80.48	80.48	80.48
Total Common Shares Outstanding	80.58	80.48	80.48	80.48	80.48	80.48
Working Capital	4,401	4,113	3,549	3,209	3,691	3,978
Book Value Per Share	154.21	148.82	123.85	101.31	86.91	76.50
Tangible Book Value	12,414	11,964	9,954	8,137	6,984	6,142
Tangible Book Value Per Share	154.06	148.66	123.67	101.10	86.77	76.31
Land	-	703.24	109.23	104.16	91.64	91.6
Buildings	-	2,024	1,291	857.69	724.16	546.76
Machinery	-	5,124	3,810	2,621	2,132	1,474
Construction In Progress	-	355.48	1,480	1,488	676.28	434.09

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error